AtriCure, Inc. has disclosed a notable stock transaction involving one of its directors, Kristine Johnson. On November 6, 2026, Johnson sold 2,452 shares of the company's common stock at an average price of $58.48 per share. This transaction is significant as it highlights the ongoing engagement of company management with their stock holdings, which can be indicative of broader market sentiments and trends within the surgical and medical instruments industry.
Background
AtriCure, Inc. is a leading company in the surgical and medical instruments sector, specifically classified under the SIC code 3841. The company trades on the Nasdaq under the ticker symbol ATRC. As a large accelerated filer, AtriCure is subject to rigorous reporting requirements, ensuring transparency in its operations and financial dealings. The company is headquartered in Mason, Ohio, and focuses on innovative solutions in the medical field.
What the Filing Says
The recent SEC filing, accession number 0001231984-26-000005, details the stock transaction executed by Johnson. The filing states, "This transaction was executed in multiple trades at prices ranging from $58.23 to $58.86 per share. The price reported above reflects the weighted average sales price." Following this transaction, Johnson holds 53,502 shares of AtriCure.
Impact
This transaction may affect various stakeholders, including investors and analysts who closely monitor insider trading activities as indicators of company performance and market confidence. The surgical and medical instruments industry, which AtriCure operates within, is highly competitive, and movements by insiders can influence perceptions of the company's future prospects.
What's Next
The filing does not say what happens next.
Read Next
Cloudflare's Michelle Zatlyn Sells Over $1.5M in Shares
Zurn Elkay VP LaMotte Jeremy L Reports Stock Sale
XTI Aerospace CEO Jeremy Schneiderman Reports Stock Exchange
Jennifer Salinas acquires 366,529 shares in Cerence Inc.
Mentz Christian acquires 125,979 shares of Cerence Inc.
Cerence CEO Acquires 819,039 Shares in Stock Transaction










